Research Article| Volume 25, ISSUE 1, P33-38, January 01, 1989

Plasma melatonin levels in depressed patients before and after treatment with antidepressant medication

      This paper is only available as a PDF. To read, Please Download here.


      Daytime melatonin was measured by radioimmunoassay in 113 depressed outpatients before and after treatment with imipramine, mianserin, phenelzine, and placebo. At baseline, elevation of daytime melatonin values above expected levels suggests nonspecificity of the assay. After 6 weeks of treatment, melatonin levels were somewhat lower in patients on imipramine, mianserin, and placebo and slightly increased in patients treated with phenelzine. Changes in melatonin levels during treatment were significantly different for phenelzine compared with the other treatments. These findings are consistent with alterations in β-adrenergic functioning or changes in serotonin levels.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Beck-Friis J
        • Von Rosen D
        • Kjellman BF
        • Ljunggren J-G
        • Wetterberg L
        Melatonin in relation to body measures, sex, age, season and the use of drugs in patients with major affective disorders and healthy subject.
        Psychoneuroendocrinology. 1984; 9: 261-277
        • Claustrat B
        • Chazot G
        • Brun J
        • Jordan D
        • Sassolas G
        A chronobiological study of melatonin and cortisol secretion in depressed subjects: Plasma melatonin, a biochemical marker in major depression.
        Biol Psychiatry. 1984; 19: 1215-1228
        • Deguchi T
        • Axelrod J
        Supersensitivity and subsensitivity of the α-adrenergic receptor in pineal gland regulated by catecholamine transmitter.
        in: Proc Nat Acad Sci USA. 70. 1973: 2411
        • Frazer A
        • Brown R
        • Kocsis J
        • Caroff S
        • Amsterdam J
        • Winokur A
        • Sweeney J
        • Stokes P
        Patterns of melatonin rhythms in depression.
        J Neural Transmiss. 1986; 21 (Suppl): 269-290
        • Halbreich U
        • Weinberg U
        • Stewart J
        • Klein DF
        • Weitzman ED
        • Quitkin FM
        An inverse correlation between serum levels of desmethyl imipramine and melatonin-like reactivity in DMI-responsive depressives.
        Psychiatry Res. 1981; 4: 109-113
        • Hamilton M
        A rating scale for depression.
        Neurol Neurosurg Psychiatry. 1960; 23: 56-61
        • Heydorn WE
        • Brunswick DJ
        • Frazer A
        Effect of treatment of rats with antidepressants on melatonin concentrations in the pineal gland and serum.
        Pharmacol Exp Ther. 1982; 222: 534-543
        • King TS
        • Richardson BA
        • Reiter RJ
        Regulation of rat pineal melatonin synthesis: Effect of monoamine oxidase inhibiton.
        Mol Cell Endocrinol. 1982; 25: 327-338
        • Klein DC
        • Moore RY
        Pineal N-acetyltransferase and hydroxyindole-O-methyltransferase: Control by the retinohypothalamic tract and suprachiasmatic nucleus.
        Brain Res. 1979; 174: 245-362
        • Klein DC
        • Rowe J
        Pineal gland in organ culture.
        Mol Pharmacol. 1970; 6: 164-171
        • Liebowitz MR
        • Quitkin FM
        • Stewart JW
        • McGrath PJ
        • Harrison W
        • Rabkin J
        • Tricamo E
        • Markowitz JS
        • Klein DF
        Phenelzine v imipramine in atypical depression.
        Arch Gen Psychiatry. 1984; 41: 669-677
        • Mendlewicz J
        • Linkowski P
        • Bronchey L
        • Weinberg U
        • Weitzman ED
        • Branchey M
        Abnormal 24 hour pattern of melatonin secretion in depression.
        Lancet. 1979; 2: 1362
        • Murphy DL
        • Belmaker R
        • Carpenter WT
        • Wyatt RJ
        Monoamine oxidase in chronic schizophrenia: Studies of hormonal and other factors affecting enzyme activity.
        Br J Psychiatry. 1977; 130: 151-158
        • Murphy DL
        • Tamarkin L
        • Sunderland T
        • Garrick NA
        • Cohen RM
        Human plasma melatonin is elevated during treatment with the monoamine oxidase inhibitors clorgyline and tranylcypromine but not deprenyl.
        Psychiatry Res. 1986; 17: 119-127
        • Oxenkrug G
        • McCouley R
        • McIntyre I
        • Filipowicz C
        Selective inhibition of MAO-A but not MAO-B activity increases rat pineal melatonin.
        J Neurol Transmiss. 1985; 61: 265-270
        • Oxenkrug GF
        • Mclntyre IM
        • Balon R
        • Jain AK
        • Appel D
        • McCauley RB
        Single dose tranylcypromine increases human melatonin.
        Biol Psychiatry. 1986; 21: 1085-1089
        • Sachar EJ
        • Asnis G
        • Halbreich U
        • Nathan RS
        • Halpern F
        Recent studies in the neuroendocrinology of major depressive disorders.
        Psychiatr Clin North Am. 1980; 3: 313-326
        • Sack RL
        • Lewy AJ
        Desmethyl imipramine treatment increases melatonin production in humans.
        Biol Psychiatry. 1986; 21: 406-410
        • Spitzer RL
        • Endicott J
        • Robins E
        Research diagnostic criteria: Rationale and reliability.
        Arch Gen Psychiatry. 1978; 35: 773-779
        • Sukow RF
        • Cooper TB
        Simultaneous determination of imipramine, desipramine and their 2-hydroxy metabolites in plasma by ion-pair reversed-phase high performance liquid chromatography with amperometric, detection.
        J Pharmaceut Sci. 1981; 70: 257-261
        • Sukow RF
        • Cooper TB
        • Quitkin FM
        • Stewart JW
        Determination of mianserin and metabolites in plasma by liquid chromatography with electrochemical detection.
        J Pharmaceut Sci. 1982; 71: 889-892
        • Tamarkin L
        • Abastillas P
        • Chen HC
        • McNemar A
        • Sidbury JB
        The daily profile of plasma melatonin in obese and Prader-Willi syndrome children.
        J Clin Endocrinol Metab. 1982; 55: 491-495
        • Thompson C
        • Mezey G
        • Corn T
        • Franey C
        • English J
        • Arendt J
        • Checkley SA
        The effect of desipramine upon melatonin and cortisol secretion in depressed and normal subjects.
        Br J Psychiatry. 1985; 147: 389-393
        • Wetterberg L
        • Apperia B
        • Beck-Friis J
        • Kjellman BF
        • Ljunggren J-G
        • Petterson U
        • Sjolin A
        • Tham A
        • Unden F
        Pineal-hypothalamic-pituitary function in patients with depressive illness.
        in: Fuxe K Gustafsson J-A Wetterberg L Steroid Hormone Regulation of the Brain. Permagon Press, Oxford1981: 397-403
        • Wetterberg L
        • Beck-Friis J
        • Kjellman BF
        • Ljunggren J-G
        Circadian rhythms in melatonin and cortisol secretion in depression.
        Adv Biochem Psychopharmacol. 1984; 39: 197-205
      1. Williams Textbook of Endocrinology. WB Saunders, Philadelphia1985: 526-528 (cd 7.)